Medicare Enrolled
Dr. Haskell Kirkpatrick, MD
Medical Oncology · Dallas, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kirkpatrick from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kirkpatrick?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kirkpatrick
Dr. Haskell Kirkpatrick is a medical oncology specialist in Dallas, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Kirkpatrick performed 158,235 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Kirkpatrick received a total of $1,333 from 27 pharmaceutical and/or device companies across 54 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kirkpatrick is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 4% volume in TX
$1,333 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗158,235
Medicare services
Top 4% in TX for medical oncology
Not available
Unique patients (not deduplicated)
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
26,190 | $2 | $20 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
21,450 | $0 | $5 |
| Pembrolizumab injection (Keytruda) | 20,600 | $43 | $137 |
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
18,200 | $0 | $2 |
| Filgrastim injection (Zarxio) for white blood cells An injection of the biosimilar medication filgrastim-sndz (Zarxio) with a dosage of 1 microgram. |
10,320 | $0 | $2 |
| Paclitaxel chemotherapy injection | 10,096 | $0 | $8 |
| Daratumumab injection (Darzalex) An injection containing daratumumab and hyaluronidase-fihj administered under the skin. |
8,280 | $38 | $127 |
| Oxaliplatin chemotherapy injection This procedure involves the administration of oxaliplatin, a chemotherapy medication, via injection. The dosage specified is 0.5 mg. |
8,200 | $0 | $33 |
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
6,120 | $0 | $5 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,827 | $0 | $1 |
| Immune globulin infusion (Octagam) This procedure involves the administration of immune globulin medication directly into a vein. It is provided in a non-lyophilized liquid form. |
2,360 | $34 | $235 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,790 | $1 | $114 |
| Bevacizumab-bvzr biosimilar injection, 10 mg An injection of bevacizumab-bvzr, a biosimilar medication, administered in a 10 mg dose. |
1,766 | $24 | $155 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,668 | $8 | $20 |
| Injection, granisetron hydrochloride, 100 mcg | 1,630 | $0 | $24 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,478 | $8 | $36 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
1,433 | $10 | $64 |
| Rituximab-pvvr biosimilar injection, 10 mg An injection of rituximab-pvvr, a biosimilar medication, administered in a 10 mg dose. |
1,370 | $20 | $181 |
| Denosumab injection (Prolia/Xgeva) | 1,320 | $18 | $66 |
| Bortezomib injection, 0.1 mg Administration of a 0.1 mg dose of bortezomib medication via injection. |
1,260 | $4 | $116 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
1,135 | $0 | $3 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
679 | $95 | $368 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
589 | $23 | $157 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
561 | $103 | $707 |
| Pegfilgrastim injection, 0.5 mg An injection of pegfilgrastim, a medication that stimulates the production of white blood cells. This specific code applies to the brand-name drug and excludes biosimilar versions. |
528 | $80 | $1,348 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
376 | $2 | $300 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
322 | $2 | $13 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 318 | $3 | $373 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
314 | $6 | $431 |
| Injection, potassium chloride, per 2 meq | 305 | $0 | $1 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
273 | $11 | $96 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
261 | $60 | $250 |
| Magnesium sulfate injection, per 500 mg An injection of magnesium sulfate administered in 500 mg increments. |
236 | $1 | $6 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
224 | $50 | $313 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
209 | $12 | $108 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
200 | $2 | $19 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
185 | $6 | $31 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
166 | $1 | $7 |
| Manual white blood cell count A laboratory test that involves examining a sample under a microscope to manually count the number of white blood cells present. |
160 | $4 | $22 |
| Complete blood count (CBC), automated An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood. |
160 | $6 | $34 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
148 | $49 | $344 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
139 | $22 | $161 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
138 | $13 | $60 |
| Iron level test | 137 | $6 | $27 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
137 | $9 | $35 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
133 | $136 | $496 |
| CA 19-9 tumor antigen test A blood test that measures the level of CA 19-9, a substance that can be found in the blood of some people with cancer. This quantitative analysis detects and measures the specific tumor antigen. |
132 | $20 | $128 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
122 | $19 | $99 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
120 | $62 | $247 |
| Cisplatin chemotherapy injection, 10 mg Administration of a 10 mg dose of cisplatin, a chemotherapy medication, via injection. |
113 | $1 | $94 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
111 | $56 | $211 |
| Immunoglobulin light chain measurement A blood test that measures the levels of immunoglobulin light chains, which are proteins produced by plasma cells. |
108 | $17 | $60 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
94 | $1 | $8 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
93 | $15 | $100 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
76 | $26 | $256 |
| Immunoglobulin level test A blood test that measures the level of gammaglobulins, which are immune system proteins. |
69 | $9 | $56 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
66 | $8 | $49 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
61 | $26 | $145 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
59 | $1 | $19 |
| PSA test (prostate cancer screening) | 53 | $18 | $94 |
| Enhanced Oncology Model monthly payment This code represents the monthly enhanced oncology services payment under the Enhancing Oncology Model. It covers the administrative payment for enhanced services provided to eligible patients. |
52 | $71 | $70 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 48 | $135 | $3,675 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
44 | $10 | $75 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
42 | $84 | $372 |
| On-body injector for subcutaneous injection A device is applied to the skin to automatically deliver a medication injection under the skin. |
41 | $15 | $96 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
37 | $44 | $289 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
37 | $117 | $565 |
| IV chemotherapy initiation with community continuation Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living. |
37 | $132 | $500 |
| Injection, lorazepam, 2 mg | 31 | $1 | $3 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
30 | $20 | $114 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
28 | $39 | $135 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
27 | $72 | $264 |
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
18 | $3 | $28 |
| Automated red blood cell count with calculations A blood test that automatically counts red blood cells and performs additional calculations to assess blood health. |
18 | $5 | $26 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
17 | $1,187 | $4,802 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 17 | $90 | $657 |
| New patient office visit, complex (60-74 min) | 16 | $163 | $709 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
14 | $102 | $470 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
13 | $66 | $821 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
6.6% high complexity
88.5% medium
4.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$1,333
Total received (2018-2024)
Avg $190/year across 7 years
Bottom 33% in TX for medical oncology
27
Companies
54
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$702
2023
$268
2022
$143
2021
$48
2020
$37
2019
$80
2018
$55
Payments by company (2024)
Kite Pharma, Inc.
$143
GlaxoSmithKline, LLC.
$66
INTUITIVE SURGICAL, INC.
$64
Tempus AI, Inc
$58
Stemline Therapeutics Inc.
$49
Incyte Corporation
$44
Bayer Healthcare Pharmaceuticals Inc.
$34
Ipsen Biopharmaceuticals, Inc
$28
Takeda Pharmaceuticals U.S.A., Inc.
$27
AstraZeneca Pharmaceuticals LP
$25
Aveo Pharmaceuticals, Inc.
$25
Merck Sharp & Dohme LLC
$24
PFIZER INC.
$23
Gilead Sciences, Inc.
$21
ABBVIE INC.
$20
Genentech USA, Inc.
$20
Janssen Biotech, Inc.
$17
ARRAY BIOPHARMA INC
$16
Top 3 companies account for 38.9% of 2024 payments
All-time payments by company (2018-2024) ›
Kite Pharma, Inc.
$206
Incyte Corporation
$124
Janssen Biotech, Inc.
$93
AstraZeneca Pharmaceuticals LP
$83
Genentech USA, Inc.
$69
GlaxoSmithKline, LLC.
$66
INTUITIVE SURGICAL, INC.
$64
Merck Sharp & Dohme LLC
$64
Tempus AI, Inc
$58
Stemline Therapeutics Inc.
$49
Takeda Pharmaceuticals U.S.A., Inc.
$47
ABBVIE INC.
$46
Novartis Pharmaceuticals Corporation
$39
E.R. Squibb & Sons, L.L.C.
$35
Bayer Healthcare Pharmaceuticals Inc.
$34
Gilead Sciences, Inc.
$32
Celgene Corporation
$29
Ipsen Biopharmaceuticals, Inc
$28
Aveo Pharmaceuticals, Inc.
$25
GENZYME CORPORATION
$24
PFIZER INC.
$23
PUMA BIOTECHNOLOGY, INC.
$19
Blueprint Medicines Corporation
$17
Astellas Pharma US Inc
$17
ARRAY BIOPHARMA INC
$16
Pharmacyclics LLC, An AbbVie Company
$14
Dova Pharmaceuticals
$12
Top 3 companies account for 31.8% of all-time payments
Associated products mentioned in payments ›
ALUNBRIG · Alecensa · DARZALEX · Da Vinci Surgical System · Doptelet · ELIQUIS · ELITEK · ELZONRIS · ENHERTU · FOTIVDA · FRUZAQLA · GAVRETO · IMBRUVICA · IMFINZI · Imbruvica · JAKAFI · KEYTRUDA · MONJUVI · NERLYNX · Nubeqa · OJJAARA · ONUREG · OPDIVO · Onivyde · Orserdu · PIQRAY · PROMACTA · RYBREVANT · SPRYCEL · Tecentriq · VENCLEXTA · XALKORI · Xtandi · Yescarta
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Medical oncologists in nearby ZIP areas
91
County median income
$74,149
Nearest hospital to ZIP centroid (approximate)
TEXAS HEALTH PRESBYTERIAN HOSPITAL DALLAS
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kirkpatrick is a mixed practice specialist, with above-average Medicare volume (top 4% in TX), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kirkpatrick experienced with darbepoetin injection (aranesp) for anemia?
Based on Medicare claims data, Dr. Kirkpatrick performed 26,190 darbepoetin injection (aranesp) for anemia services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Kirkpatrick receive payments from pharmaceutical companies?
Yes. Dr. Kirkpatrick received a total of $1,333 from 27 companies across 54 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kirkpatrick's costs compare to other medical oncologists in Dallas?
Dr. Kirkpatrick's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kirkpatrick) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in Dallas
Browse medical oncologists in Dallas ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in TX
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in TX
Which TX medical oncologists receive the most from drug and device companies.
By company
Kite Pharma, Inc. Payments to Doctors
See all physicians who received payments from Kite Pharma, Inc.
By company
Incyte Corporation Payments to Doctors
See all physicians who received payments from Incyte Corporation.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology